| White Blood Cell Infusions to Treat HIV Infection (NCT00001647) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Immune Activity Against CVM Retinitis (NCT00001611) | National Eye Institute (NEI) | 1997-02-01 |
| Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers (NCT00001560) | National Cancer Institute (NCI) | 1996-12-24 |
| Fluconazole Prophylaxis of Thrush in AIDS (NCT00001542) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-07-01 |
| Thalidomide to Treat Oral Lesions in HIV-Infected Patients (NCT00001524) | National Institute of Dental and Craniofacial Research (NIDCR) | 1996-06-01 |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits (NCT00001500) | National Cancer Institute (NCI) | 1996-04-01 |
| Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers (NCT00001538) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-03-01 |
| Twins Study of Gene Therapy for HIV Infection (NCT00001535) | National Human Genome Research Institute (NHGRI) | 1996-03-01 |
| A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection (NCT00001443) | National Cancer Institute (NCI) | 1995-07-01 |
| Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting (NCT00004664) | National Center for Research Resources (NCRR) | 1995-06-01 |
| Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist (NCT00001475) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-01 |
| Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children (NCT00001435) | National Cancer Institute (NCI) | 1995-04-01 |
| Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis (NCT00004794) | National Center for Research Resources (NCRR) | 1995-03-01 |
| Viral Activation Transfusion Study (VATS) (NCT00000593) | National Heart, Lung, and Blood Institute (NHLBI) | 1994-11-01 |
| Evaluation and Natural History of Children With Cancer and AIDS (NCT00001424) | National Cancer Institute (NCI) | 1994-11-01 |
| Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications (NCT00001409) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-09-01 |
| Tuberculosis in a Multiethnic Inner City Population (NCT00005379) | NYU Langone Health | 1994-08-01 |
| Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection (NCT00001386) | National Cancer Institute (NCI) | 1994-06-01 |
| Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs (NCT00001353) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Interleukin-2 Therapy for HIV Infection - Supplemental Procedures (NCT00001354) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) (NCT00000134) | Johns Hopkins Bloomberg School of Public Health | 1992-12-01 |
| Ganciclovir Implant Study for Cytomegalovirus Retinitis (NCT00000118) | National Eye Institute (NEI) | 1992-10-01 |
| HIV Diversity and Pathogenesis in Donor-Recipient Clusters (NCT00005360) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-08-01 |
| Cardiac Autonomic Control in Children of HIV Positive Mothers (NCT00005353) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-06-01 |
| Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) (NCT00000590) | National Heart, Lung, and Blood Institute (NHLBI) | 1991-09-01 |
| A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine (NCT00001267) | National Cancer Institute (NCI) | 1990-10-01 |
| Prospective Study of HIV Infection in Hemophiliacs (NCT00005309) | Bloodworks | 1990-07-01 |
| Retrovirus Epidemiology Donor Study I (REDS I) (NCT00005278) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-07-01 |
| Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) (NCT00005274) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-05-01 |
| Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection (NCT00000587) | Thomas Jefferson University | 1988-09-01 |
| A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy (NCT00270283) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-07-01 |
| AIDS-Associated Heart Disease -- Incidence and Etiology (NCT00005228) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| AIDS-Associated Cardiomyopathy (NCT00005227) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| HIV-Associated Heart Disease (NCT00005229) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| Pulmonary Complications of HIV Infection Study (PACS) (NCT00005273) | National Heart, Lung, and Blood Institute (NHLBI) | 1987-09-01 |
| Effectiveness of AIDS Antibody Screening (NCT00005303) | National Heart, Lung, and Blood Institute (NHLBI) | 1986-09-01 |
| Transfusion Safety Study (TSS) (NCT00005301) | National Heart, Lung, and Blood Institute (NHLBI) | 1984-09-01 |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease (NCT00269945) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs (NCT00051766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy (NCT00270270) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease (NCT00270010) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |